Human monoclonal antibodies specific for gp120 and gp41 and hybridomas for their production
CA 1339858 C · Owner: Sugano, Toru · Inventors: Petersen, Eskild; Hersh, Evan; Matsumoto, Yoh-Ichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Human monoclonal antibodies which belong to the IgG1 subclass and which are specific for HIV gp41 and gp120 along with the, hybridomas producing them are described. Also described is a method for producing human monoclonal antibodies which does not involve transformation by Epstein-Barr virus. These hybridomas are formed by fusing mouse myeloma cells and lymphocytes from the lymph nodes of HIV-seropositive donors. The monoclonal antibodies produced by HB 9669 and HB 9670 are predicted to be useful in the diagnostic prevention and, therapy of HIV infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 5, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 5, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.